[1]
Dr. F. Anto Nazarene et al. 2025. NEUROPHYSIOLOGICAL CHANGES AND SERUM ANTINUCLEAR ANTIBODY LEVELS IN DEMENTIA AND HIGH-RISK GROUPS. Journal of Population Therapeutics and Clinical Pharmacology. 32, 10 (Dec. 2025), 1801–1813. DOI:https://doi.org/10.53555/j96gax27.